Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1997 1
1998 2
1999 3
2000 1
2001 3
2002 5
2003 5
2004 4
2005 3
2006 3
2007 4
2008 5
2009 6
2010 2
2011 6
2012 7
2013 2
2014 4
2015 2
2016 11
2017 14
2018 15
2019 12
2020 10
2021 8
2022 12
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. Among authors: belachew s. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. Among authors: belachew s. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.
Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, Model F, Koendgen H, Manfrini M, Belachew S, Hauser SL. Kappos L, et al. Among authors: belachew s. JAMA Neurol. 2020 Sep 1;77(9):1132-1140. doi: 10.1001/jamaneurol.2020.1568. JAMA Neurol. 2020. PMID: 32511687 Free PMC article. Clinical Trial.
[Depression and neuroplasticity].
Pitchot W, Polis M, Belachew S, Ansseau M. Pitchot W, et al. Among authors: belachew s. Rev Med Liege. 2008 May-Jun;63(5-6):372-7. Rev Med Liege. 2008. PMID: 18669207 Free article. Review. French.
Adult neurogenesis and the diseased brain.
Vandenbosch R, Borgs L, Beukelaers P, Belachew S, Moonen G, Nguyen L, Malgrange B. Vandenbosch R, et al. Among authors: belachew s. Curr Med Chem. 2009;16(6):652-66. doi: 10.2174/092986709787458371. Curr Med Chem. 2009. PMID: 19199929 Review.
[Vitamin D tweets light to genes in multiple sclerosis].
Lommers E, Lecrompe L, Moonen G, Phan-Ba R, Belachew S. Lommers E, et al. Among authors: belachew s. Rev Med Liege. 2012 May-Jun;67(5-6):359-65. Rev Med Liege. 2012. PMID: 22891491 Free article. Review. French.
144 results